Stepan Company produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in North America, Europe, Latin America, and Asia. The company is headquartered in Northfield, Illinois.
120 articles
Stepan Company reported a 64% year-over-year increase in Q3 net income to $17.8 million, driven by higher selling prices and efficiency savings from Project Catalyst across its surfactant, polymer, an
Stepan Co. reported third-quarter net income of $17.8 million and revenue of $468.2 million, with adjusted earnings per share reaching 94 cents.
Stepan Company has launched its Q3 2026 earnings call, with executives set to discuss financial results and answer analyst questions. The session provides critical insights into the company's performa
Stepan Company declared a quarterly cash dividend of $0.405 per share, marking its 59th consecutive year of increases. The specialty chemical manufacturer serves industries including cleaning, agricul
Stepan Company has increased its quarterly cash dividend to $0.405 per share, marking its 59th consecutive year of dividend increases. This move reinforces the company's long-running dividend growth p
Stepan Company reported third-quarter earnings per share of $0.94, exceeding analyst estimates by 21 cents. Revenue also surpassed expectations, reaching $692.15 million against a consensus of $634.3
Stepan Company reported strong Q3 2026 results with 18% EBITDA growth driven by volume and margin recovery. Its Project Catalyst initiative exceeded savings targets, contributing to significant net in
TradingView provides financial data and analyst estimates for Stepan Company, allowing users to explore reported financial data across income statements, balance sheets, and valuation metrics.
Argus Research lowered its price target for Stepan Company to USD 65.00 ahead of the Q3 earnings release on October 28. Investors will monitor the report to assess operational execution against the re
Stepan Company has scheduled its third-quarter earnings release for October 28, 2026, attracting investor attention in the specialty chemicals sector. Current stock metrics show a EUR 55.25 price, 31.
Dimensional Fund Advisors LP increased its stake in specialty chemicals manufacturer Stepan Co by 66,990 shares to 5.20%. Despite negative profitability trends, the stock is considered modestly underv
Stepan Company announced it will release Q3 2026 earnings on October 28, 2026, accompanied by a conference call at 9 a.m. ET. This disclosure offers critical financial insights from a major chemical m
Dimensional Fund Advisors LP disclosed a 5.2% passive stake in Stepan Co (SCL) via managed funds as of September 30, 2026. No single fund holds more than 5% of the company's securities.
Stepan Company will release its Q3 2026 earnings on October 28, 2026, at 7:00 a.m. ET, accompanied by a conference call to discuss financial and operational performance.
Stepan Company (NYSE: SCL) will release its Q3 2026 earnings on October 28, 2026, at 7:00 a.m. ET. A conference call led by CEO Luis Rojo and CFO Ruben Velasquez will follow at 9:00 a.m. ET.
Zacks Research upgraded Stepan Company stock to Strong Buy after Q2 2026 earnings beat consensus, reporting adjusted EPS of USD 1.18 and revenue of USD 684.11 million.
Stepan Company reported 15% revenue growth to $684.11 million in Q2 2026, beating analyst estimates with an adjusted EPS of $1.18. Analysts upgraded the stock to "Strong Buy" with a price target of $8
Stepan Company secured a $500 million credit facility led by JPMorgan Chase and Bank of America, boosting borrowing capacity by $50 million for working capital and acquisitions.
Stepan Company (SCL) stock overview covers financial metrics and analyst insights across its Surfactants, Polymers, and Specialty Products segments. The report highlights the company's global operatio
Stepan Company shares closed at $61.81 on September 22, 2026, slipping 0.11% while the Nasdaq rose 2.26%. As a specialty chemicals operator, the stock's performance diverged from broader market trends
Stepan Company's stock dipped slightly after recent gains, following results showing a 4% revenue increase but a 14% drop in diluted earnings per share due to margin pressure. Investors are monitoring
Empowered Funds LLC increased its stake in specialty chemical maker Stepan by $4.95 million after the company surpassed Q2 revenue and EPS expectations.
Stepan Company reported mixed Q2 2026 financial results with stronger earnings but a six-month net loss while maintaining dividends, prompting investor analysis on converting specialty chemical assets
Various ETFs include Stepan Co stock in their portfolios, detailing fund metrics like AUM and expense ratios. This information assists investors in identifying diversified investment options primarily
Stepan Company shares have recovered over the past year despite a five-year decline, trading near their fair price-to-sales value of 0.6x. Future performance hinges on converting revenue to cash flow
Stepan Company reported approximately 2,301 employees worldwide as of March 2026, marking a 3.8% decline since 2023. Active job postings decreased by 60.9%, while the average global salary stands at $
Empowered Funds LLC increased its stake in Stepan Company by 124.8% to $8.7 million following strong quarterly earnings that beat estimates with 15% revenue growth.
Stepan Company exceeded Q2 revenue and earnings estimates, though analysts forecast a loss by 2026 despite higher price targets. The company is projected to grow faster than the broader industry throu
Stepan Co CFO Ruben Dario Velasquez settled 1,358 RSUs at $64.675 per share on August 10, 2026, withholding 398 shares for taxes. The remaining 2,716 RSUs will vest ratably over three years without a
Wall Street Zen upgraded Stepan Company (NYSE:SCL) to a "Buy" rating following strong quarterly earnings that exceeded EPS and revenue expectations. The positive outlook drove shares up 1.8% to $65.14
ChemBrief